TEIJINHuman Chemistry, Human Solutions

Teijin Pharma Limited GLOBAL

  • Site Map
  • Contact Us
  • Enlarge Text

menu

  • About Us
  • Our Business Structure
  • Site Map
  • Contact Us

About Us:TOP

  • Corporate Philosophy
  • Message from the President
  • Group Synergies
  • Office Locations
  • Alliance Partners
  • History
  • Corporate Social Responsibility
  • Project Stories
  • News

Our Business Structure:TOP

Business Fields
  • About Teijin Pharma
Business Activities
  • Research & Development
  • Industrial Technology
  • Regulatory Compliance

  • Japan Local Site日本

Home > Notice

Notice

Latest Notice

RSS

Apr. 14, 2020
  • Teijin Pharma and Teijin Healthcare's Initiatives for COVID-19 (2)
  • Teijin Pharma and Teijin Healthcare's Initiatives for COVID-19 (1)
Mar. 10, 2020
  • Teijin Pharma to Supply Ciclesonide for COVID-19 Clinical Research
Mar. 28, 2019
  • Teijin Pharma posts Project Stories Vol. 11 Innovative Rehabilitation Devices for Stroke Patients
Feb. 04, 2019
  • Teijin Board Elects Ichiro Watanabe as New President of Teijin Pharma
Nov. 19, 2018
  • Teijin Pharma posts Project Stories Vol. 10 Enabling First Class Care at Home
Jul. 27, 2018
  • Teijin Pharma posts Project Stories Vol. 9 Celebrating Teijin Pharma’s History as a Core Part of Teijin
May. 07, 2018
  • Teijin Pharma updates Project Stories Vol. 3 Building a Strong Platform in the Field of Bone and Joint Diseases
Mar. 31, 2017
  • Teijin Pharma updates Project Stories Vol. 5 Creating Products to Match Medical Needs
  • Teijin Pharma updates Project Stories Vol. 1 A New Drug Born from R&D

Page Top


Notice

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • News Release

We use cookies to help improve your experience on our website. Clink on "Agree" to agree and proceed, or click on "See Details" for more information and settings of cookies.

See Details
  • Terms & Conditions of Use
  • Privacy Policy

Copyright © Teijin Pharma Limited. All Rights Reserved.